Home / Health / Birth Control Uncovered Rare Uterine Cancer
Birth Control Uncovered Rare Uterine Cancer
28 Oct
Summary
- Birth control use led to discovery of rare uterine cancer.
- Continuous bleeding was the first major symptom noticed.
- Early detection led to a full recovery and cancer-free status.
Claudia Pereira's journey to manage acne inadvertently led to the discovery of a rare uterine cancer. After starting birth control at age 37 to address blemishes, she experienced persistent, months-long bleeding.
Initially advised that the bleeding might be a side effect of the medication, Pereira's concern grew as it continued. The situation escalated when the bleeding transformed into a thick discharge, prompting her to seek medical attention.
Diagnostic tests, including an MRI and ultrasound, revealed a significant mass. Pathology confirmed it was uterine leiomyosarcoma, a rare cancer developing in the uterus's smooth muscles, a diagnosis that initially caused immense fear and panic.
Uterine leiomyosarcoma is an uncommon cancer, accounting for a small percentage of all uterine and overall cancer cases. Pereira's diagnosis at under 50 was particularly unusual, as this cancer typically affects older individuals.
Pereira's tumors tested positive for hormone receptors, suggesting that the birth control's added hormones likely accelerated the cancer's growth, leading to its discovery. Doctors believe this medication inadvertently facilitated its detection.
Following surgical removal of the mass, scans showed no signs of spread. A subsequent hysterectomy further ensured no disease remained, bringing immense relief. Pereira has now been cancer-free for over a year and is living life to the fullest.
Her story underscores the critical importance of self-advocacy in healthcare. Pereira urges others to listen to their bodies and seek medical advice promptly, emphasizing that early detection significantly improves outcomes for rare conditions.
